Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000933430-20-000014
Filing Date
2020-12-02
Accepted
2020-12-02 16:22:50
Documents
1
Period of Report
2020-12-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4409
  Complete submission text file 0000933430-20-000014.txt   5847
Mailing Address 1603 ORRINGTON AVE., STE 900 EVANSTON IL 60201
Business Address
WHITMORE BRADFORD T (Reporting) CIK: 0000933430 (see all company filings)

State of Incorp.: IL | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 201364036

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations